Prentice Wealth Management LLC Marker Therapeutics, Inc. Transaction History

Prentice Wealth Management LLC

  • $371 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$0.26 - $0.46 $325 - $575
-1,250 Closed
0 $0
Q1 2021

Jun 17, 2021
SELL
$1.47 - $3.29 $2,278 - $5,099
-1,550 Reduced 55.36%
1,250 $3,000
Q1 2021

Jun 08, 2021
BUY
$1.47 - $3.29 $4,116 - $9,212
2,800 New
2,800 $3,000

Others Institutions Holding MRKR

# of Institutions
4
Shares Held
401K
Call Options Held
0
Put Options Held
0
View Full List

About Marker Therapeutics, Inc.

MRKR Quotes by TradingView
  • Ticker MRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,599,200
  • Market Cap $109M
  • Description
  • Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...
More about MRKR
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email